No Record Found
Sector
PharmaceuticalsOpen
₹499Prev. Close
₹499Turnover(Lac.)
₹0.78Day's High
₹509.95Day's Low
₹49952 Week's High
₹89652 Week's Low
₹442.55Book Value
₹563.59Face Value
₹10Mkt Cap (₹ Cr.)
181.46P/E
9.83EPS
51.72Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 3.57 | 3.57 | 3.57 | 3.57 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 197.63 | 173.92 | 151.23 | 152.48 | 
| Net Worth | 201.2 | 177.49 | 154.8 | 156.05 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Revenue | 96.56 | 70.57 | 92.47 | 95.47 | 
| yoy growth (%) | 36.82 | -23.67 | -3.13 | 23.96 | 
| Raw materials | -50.06 | -40.02 | -53.57 | -48.67 | 
| As % of sales | 51.84 | 56.71 | 57.93 | 50.98 | 
| Employee costs | -10.18 | -9.7 | -8.56 | -6.75 | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Profit before tax | 17.59 | 9.11 | 18.04 | 24.88 | 
| Depreciation | -1.98 | -2 | -1.56 | -1.55 | 
| Tax paid | -4.05 | -1.98 | -5.6 | -8.26 | 
| Working capital | 11.57 | 22.79 | -3.33 | 10.21 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 36.82 | -23.67 | -3.13 | 23.96 | 
| Op profit growth | 199.58 | -65.14 | -34.33 | 41.59 | 
| EBIT growth | 92.21 | -49.25 | -27.44 | 42.53 | 
| Net profit growth | 90.09 | -42.7 | -23.62 | 31.45 | 
No Record Found
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.6 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,653.65 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.5 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,600.9 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,445.75 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Girish Dhameja
Non Executive Director / Chief Financial Officer
Sushma Chinchane
Independent Non Exe. Director
Saurabh Shah
Independent Non Exe. Director
Malay Doshi
Non Executive Director
Rajendrasinh Rana
Independent Non Exe. Director
Pooja Hindia
Company Sec. & Compli. Officer
DHWANI KARNA DESAI
SF-206 Silver Oak Complex,
BPC Road,
Gujarat - 390020
Tel: 91-022-2500 5245/46
Website: http://www.corallab.com
Email: cs@corallab.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Coral Laboratories Limited (CLL) was established in February, 1997. Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. The Company produces various pharmac...
Read More
Reports by Coral Laboratories Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.